BPC-157 significantly promotes angiogenesis by enhancing vascular endothelial growth factor receptor-2 (VEGFR2) activity and nitric oxide signaling through activation of the Akt-endothelial nitric oxide synthase (eNOS) pathway
It is a nootropic drink that comes packaged in 1oz liquid shots
Hydration supports digestion and weight loss
BPC-157 typically 200-500mcg daily, GHK-Cu 1-3mg daily, Thymosin Beta-4 2-5mg twice weekly
Week-by-week tracking template For each injection, record the following: Date and time of injection Dose in mg (prescribed amount) Concentration of vial (mg/ml) Units drawn on syringe Injection site (rotate between abdomen, thigh, upper arm) Side effects (none, mild, moderate, severe) Weight (weekly, same scale, same conditions) Notes (food tolerance, energy levels, appetite changes) This data becomes invaluable when making titration decisions with your provider
A licensed physician or nurse practitioner examine this information and may perform a virtual consultation and concludes on the medically appropriate use of GLP-1 therapy
